Abstract Angiotensm II stimulates secretion of corticosteroids and ouabam-like activity from adrenocortical cells Distmct adrenocortical angiotensm II receptor subtypes (AT,, AT*) have been described, and the present studies investigated their roles in steroid secretion Using pnmary bovine adrenocortlcal cell cultures under serum free conditions, anglotensm II stimulated the secretlons of aldosterone, cortisol, and endogenous ouabam as venfied by high-performance chromatography The dose-response curves for stimulated steroid secretion were parallel with unitary slopes while the half-maximally effective concentrations of angiotensm II were 0 31 to 0 38 nmol/L for secretions of aldosterone and cortisol and 2 3 nmol/L for endogenous ouabam The nonselective mammalian antagonist (Sar'-Ile') angiotensin II blocked stimulated secretion of all three steroids without affectmg basal output In the presence of the AT, antagonist DuP753, anglotensm II-stimulated secretions of aldosterone and cortlsol were blocked while secretion of endogenous ouabam was unaffected In the presence of the AT2 antagonist PD1233 19, both basal and angiotensm II-stimulated secretions of aldosterone and cortisol were normal while stimulated secretion of endogenous ouabam was mhibited The secretion of endogenous ouabam was activated maximally by the AT2 agonist CGP42112 under conditions m which aldosterone secretion was unaffected These results demonstrate that AT2 receptors stimulate secretion of endogenous ouabam from bovine adrenocortical cells The specsficity of AT, and AT, receptor stimulation mdicates that separate signaling mechanisms havmg rnnumal cross talk control the adrenocortical secretions of corticosteroids and cardiac-active steroids Adrenocortical AT2 receptors may be important m the adaptation to low salt diets and other conditions In which angiotensm II 1s increased (Hypertension. 1997 T he effects of anglotensm II (AII), the octapeptlde of the remn-angiotensin system, are mediated pnmarlly by angiotensm receptors present on the extracellular surface of target cells 1 The physiological actions of AI1 include the stlmulatlon of aldosterone secretlon from adrenocortlcal cells At least two different AI1 receptor subtypes, termed type 1 (AT,) and type 2 (AT,), have been Identified with the use of receptor antagomsts. Both receptor subtypes have been cloned,z-5 and the AT, subtype accounts for 80% of the angiotensm II receptors m the rat and bovine adrenal, the other 20% being the AT2 subtype.6$7
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Studies with ATI-and AT,-specific antagonists have shown that most of the known physiological effects of AII, mcludmg stimulation of adrenocortical steroid secretion, are medlated by the ATI receptor.* The physlologlcal role of the AT2 receptor in the adrenal gland 1s not known AT2 receptors have been shown to modulate T-type calcium channels m NG108-15 neuroblastoma/ glloma cells and synthesis of prostaglanchns in human astrocytes 9.10 In the rat zona glomerulosa and PC12W cells, stlmulatlon of AT2 receptors appears to reduce guanylate cyclase activity, I 1 and m vascular smooth muscle From the Departments of Physiology (J L , J R S , 2 L , J.M H ) and Medicme (B P H ), University of Maryland School of Medicine, Baltimore
Correspondence to John Hamlyn, Department of Physiology, School of Me&me, Utnverslty of Maryland, 655 W Baltimore St, Balhmore, MD 21201 0 1997 American Heart Assoclatlon, Inc cells, growth m high serum media appears to reduce the ability of AT2 receptors to bind AI1 12 A steroidal compound having remarkable similarity to ouabain has been described in mammalian plasma, urine, and tissues including the adrenal gland. 13-15 Recent studies show that the compound m the human clrculatlon and bovme hypothalamus 1s an isomer of ouabam.16-ls The observation that the plasma levels of this compound are dependent upon the integrity of the adrenal cortex 14.19 20 has led to the suggestion that this isomer may be synthesized by the adrenal gland and 1s a putative "endogenous ouabam" (EO). We have described the secretion of EO from bovme adrenocortlcal cells m primary culture and shown stimulatory effects of AI1 21.22 To further examme the action of AII, we studled the effects of several angiotensin receptor antagonists on the secretlon of EO, aldosterone, and cortisol. The results show that AI1 dose-dependently stimulates secretIon of EO from bovine adrenocortical cells mediated specifically by AT2 receptors
Methods

Adrenocortical Cell Culture
Bovine adrenal glands were obtained from a local slaughterhouse and transported to the laboratory m PBS on ice Processing of the glands to produce either mixed adrenocortical cells or zona glomernlosa-enrlched cells was performed by methods described elsewhere 21.22 In each case, the tissue pieces were washed five times with Ice-cold PBS and minced with a scalpel and forceps in F12 me&a contammg 1 5 mg/mL collagenase and 25 hg/mL DNAse (Worthington Enzymes) Tissue fragments were digested for four periods of 30 minutes on a shaker platform at 37°C Digestion was terminated by adding the digestion mixture to icecold horse serum followed by centnfugatlon at 1OOOg for 10 minutes The cell pellets were washed twice with Ice-cold DMEM contammg 0 1% BSA The cell preparations were purified on discontmuous Percoll gradients, harvested, and resuspended in CDMEM containing 10% horse serum, 2% fetal bovme serum, and pemcilhn 100 U/mL, streptomycin 0 1 mg/mL, and amphotericm B 0 25 lg/mL In some experiments, the serum concentration was altered systematically as indicated Ahquots of the cell suspension were plated out on 6 well plates (2 mUwell) to contam approximately 4 million cells per well, and the cells were grown at 37°C m 95%/5% adCOp Typical yields were 200 to 350 ttulllon cells from five adrenal glands At platmg, viability was >93% by trypan blue exclusion After 24 hours, the cell culture media was discarded and replaced with 2 mLlwel1 of fresh CDMEM
Steroid Secretion Experiments
Secretion experiments were performed on cells 42 to 48 hours after plating At this time, the culture media was removed, and cells were washed twice with a buffered SM containing (m mmol/L). NaCl154, KC1 5, CaClz 1, MgClz 5 5, HEPES 1 8, and glucose 5 6, pH 7 4 The SM alone (6 mL) or contanmg various pharmacological agents was added to each well, and the cells were incubated at 37°C m 5% CO1 for 2 to 4 hours as mchcated After incubation, the media were harvested and centrifuged to remove free cells. The supernatants were divided, and one portion was used for cortisol and aldosterone assays without extraction while the remainder was acidified with an equal volume of water contammg 0.1% rechstilled trifluoroacetlc acid and extracted usmg Cl8 Bond Elut columns (Vanan) After washing, bound EO was eluted with 25% acetomtnle, and followmg vacuum drying, the sample was reconstituted m buffer for RIA The cells were rinsed with SM, disrupted with 1 mL of 1% SDS, and assayed for protein (BCA method, Pierce Chemical Co) Steroid RIAs Followmg cell mcubahon, the cortisol and aldosterone contents of the secretion medium were measured directly using commercially available RIA kits @iagnostIc Products Corp) Neither RIA exhIbIted detectable cross-reactlvlty to ouabam at concentrations up to 10 pmol/L or to the secreted EO The cortisol RIA mtra-assay and mterassay CVs were 7 7% and 9.8%, respectively. The aldosterone mtra-assay and mterassay CVs were 5 5% and 6 9%, respectively EO was measured by RIA as previously described 23 Reconstituted Cl8 extracted material was assayed utihzmg a rabbit antiouaban antiserum shown previously to cross-react equally with human EO and ouabam 24 The assay had no significant crossreactivity (<O 01%) with cortisol, aldosterone, adrenocorticotropic hormone, AII, or any of the drugs used Intra-assay and mterassay CVs were 4 3% and 9 6%, respectively, for these experiments
High-Performance Chromatography
In some cell-incubation experiments, the secretion media were harvested, acidified with an equal volume of water containing 0 1% redistilled tnfluoroacetic acid, passed through 0 2+m nylon filters, and pumped onto a Beckman model 342 chromatograph with a semipreparative scale (10X250 mm) C 18 column at a flow rate of 3 mL/mm Bound materials were eluted with a gradient program of acetomtnle as described IJ Fractions of 3 mL were collected, dried by vacuum centnfugation, and assayed as described above Regression and Statistical Analyses Dose-response curves for AI1 were fitted to the mchcated equation by iterative nonlinear regression using a personal computer 25 Evaluations of sigmficance were performed using ANOVA 
Results
Before mvestigatmg the effects of AI1 receptor antagonists, we investigated the effect of the serum content of the CDMEM on the basal and AII-stimulated secretlon of aldosterone and EO from zona glomerulosa cells Rg 1 shows that growth of the cells m CDMEM containing serum ranging from 0.3% to 12% had no significant effect on the basal secretion of aldosterone from washed cells incubated under serum-free condlttons However, the cells grown in CDMEM contalmng 0 3% and 12% serum showed a threefold and fivefold increase m aldosterone secretion m response to AII, respectively
In contrast, the amount of EO secreted under both basal and AI1 condltlons was highest rn cells grown m CDMEM contammg 0 3% serum and lowest m cells grown m CDMEM containing 12% serum However, the ratio of the AII-&mu-lated to basal secretions was greatest (Mthreefold) m the cells grown m 12% serum, and we chose that growth condrtlon for the subsequent expenments. The EO content of the native sera used for growing the cells m these expenments was 0 58 nmol/L.
Fig 2 shows the effect of AI1 (10 and 100 nmol/L,) on the secretion of EO, aldosterone, and cortlsol from mixed adrenocorhcal cells. In each case, the effects of AI1 were dose dependent and relative to basal output, 10 nmol/L AI1 stimulated the secretion of aldosterone, cortlsol, and EO by 2 4-, 4 2-, and 2 7-fold, respectively Follow-up experiments shown m Fig 3 examined tall. In each case, the dose-response curves were parallel, sigmoidal m nature, showed Hill coefficients between 0.9 and unity, and exhibited maximal responses between lo-" and lo-' mol/L AI1 The concentrattons of AI1 that halfmaximally stimulated aldosterone and cortisol secretions, derived from iterative nonlinear regression analyses, were 0 383 and 0 314 nmol/L, respectively For EO secretion, the E& for AI1 was 2 28 nmol/L, and maximal secretion occurred at concentrations > 10 nmol/L The concentrations of AI1 required to stimulate aldosterone and EO se- cretion 10% above baseline were ~42 and =250 pmol/L, respectively. In subsequent experiments using AI1 receptor antagonists, a concentration of AI1 (10 nmol/L) was selected. This dose increased the secretton of all three steroids to values >85% of maximal while permitting reasonable concentrations of AI1 receptor hgands to be used The results of HPLC of the serum-free secretion medium following a 4-hour mcubation with mixed cells m the presence and absence of 10 nmol/L AI1 are shown m Fig 4 Immunoassay of the fractions with the appropriate techniques showed three primary peaks of immunoreactivity at fractions 20, 47, and 49 corresponding to EO, aldosterone, and cortisol, respectively. In each case, the peaks were baseline resoIved and the retention times of the secreted materials were mdistmgmshable from tracer amounts of pure standards run under the same conditions immediately followmg the sample runs In response to AII, the amount of immunoreactivity m each peak was increased >5-fold In addition to the major peak of EO m fraction 20, a small peak of lmmunoreactlvlty was found in fraction 18 that, based on retention characterlstlcs and immunoreactlvlty, appears to be the aglycon of EO (AGEO).
To determine whether the stimulatory effect of AI1 on EO secretion was medlated by a direct action of AI1 bmdmg to anglotensm receptors, the effect of a well-characterlzed peptlde anglotensm receptor antagonist, SI-AII, was evaluated SI-AI1 inhibits AI1 bmdmg to both the AT1 and AT2 receptor subtypes and blocks AII-stlmulated aldosterone secretion m mammals 6~26~27 As shown m Fig 5, SI-AI1 (0.5 pmol/L) had no effect on the basal secretions of aldosterone, cortisol, and EO (P> 05 versus control for all three steroids) from mixed cells. In the presence of 10 nmol/L AII, the secretions of each of the three adrenal steroids measured were significantly increased (P< 0001 versus control for all) while SI-AI1 completely blocked the stlmulatlon by AIL These results show that the AII-stimulated secretion of each steroid measured 1s blocked by a nonselective antagonist of mammalian angiotensm receptors Experiments with specific AT, and AT2 receptor antagonists were performed to determine whether a specific anglotensm receptor subtype mediates the stlmulatory effect of AI1 on EO secretion. DuP753 (losartan), a nonpeptlde AT, receptor antagonist, has been shown to selectively mhlblt AII binding to AT, receptors and block the stlmulated secretion of aldosterone and cortlsol 6~6-29 As shown m Fig 6, DuP753 (20 pmol/L) had no effect on the basal secretions of any of the steroids measured (P>.O5 versus control for all) from mixed cells As expected, DuP753 blocked the AII-stimulated secretions of aldosterone and cortlsol (DUP+AII versus control, P> 05 for both sterolds), whereas this antagonist had no effect on stimulated secretion of EO (DUP+AII versus control, P<.OOl) These results suggested that AII-stimulated secretion of EO was not mediated by AT, receptors, and studies with AT,-selective hgands were performed As shown m Rg 7, the AT2 antagontst PD (2 pmol/L) had no effect on the basal secretions of the three steroids 
Discussion
These studies show that AI1 stimulates the secretions of EO, aldosterone, and cortisol from primary cell cultures of bovine adrenal cortex in a manner that is dose dependent and mediated by AI1 receptors Importantly, the results obtained using selective antagonists of angrotensm receptors demonstrate that the effects of AI1 on EO secretion are mediated by the AT2 subtype This appears to be the first indrcatton of a role for this class of AI1 receptors as a mediator of steroid secretion m the adrenal gland.
The concentratrons of the agonist and antagonists used were chosen carefully from analysis of the literature so that the aldosterone and cortrsol responses m our system would be comparable to other reports. Accordingly, we chose a concentration of AI1 of 10 nmol/L because, m agreement with other reports, this stimulated steroid secretion to values >90% of maximal,29JO and this dose allowed for dtscrrmmatmg effects with reasonable doses of the angrotensin receptor antagonists. The results obtained confirmed previous reports that AI1 mediates its stimulatory effects on aldosterone and cortrsol secretion exclusively through the AT, receptor subtype.6,*7-30 We felt that measurements of EO secretion along with cortrsol and/or aldosterone in each of the experiments provided a critical demonstrahon of the functional integrity of the cell-culture system under our laboratory conditions Furthermore, the results from HPLC confirm measurement of the desired steroids under these conditions Before investigation of the role of AI1 receptors m EO secretion, our attention was directed to a report by Kambayashi et al'2 m which high serum decreased AT2 receptor binding in cultured vascular smooth muscle cells. Accordingly, we evaluated whether the serum content over the range of 0.3% to 12% m the growth medrum affected the AII-stimulated secretrons of aldosterone and EO mto a serum-free secretion medium (Fig 1) . The results showed that while the basal secretion of aldosterone was not affected, the secretion sttmulated by AI1 was greatest m cells grown m 12% serum. In contrast, the basal and AII-strmulated secretions of EO were greatest m cells grown m 0.3% or 1% serum, but the ratio of the stimulated to basal EO secretion was largest in the cells grown in medium containing 12% serum, and so subsequent studies employed cells grown under that condrtron.
The suppressive effects of culture m a high-serum medium on AII-stimulated EO secretion parallel the antmpated consequences of reduced binding of AI1 by AT2 receptors in vascular smooth muscle cells described by others.12 However, the low basal secretion of EO from cells cultured in high-serum media suggests that other mechanisms independent of AT2 receptors are affected under these conditions Kinetic studies have shown that the secretton of EO by adrenocortical cells slows as the concentration of EO rises m the external medmm.21 This phenomenon was attrrbuted to local negative feedback mhibitron by EO or a cosecreted factor and provided an early indtcatton that the control mechanisms for EO secretion differed from those involved in aldosterone and cortrsol secretions. The concentratron of EO m the mixed sera we employed for cell culture m these experiments was 0.58 nmol/L. Thus, in the growth media containing 0 3% or 12% serum, the nominal concentratrons of EO were 0.00174 and 0.0696 nmol/L, respectively, a difference of 40-fold. The latter concentrations of EO are in the lower range where some degree of direct feedback inhibition would be expected based on a previous study.21 However, direct feedback inhibition 1s an unlikely explanation for the low basal secretion of EO from cells grown in high-serum medium since all secretion expenments used washed cells incubated in the absence of serum In these expenments, direct feedback mhrbrtton by serum-derrved EO 1s an unlikely explanation for the low basal secretion. Moreover, the observatrons that growth m hrgh-serum media suppresses basal EO but not aldosterone secretion and that the former effect 1s seen in washed cells indicate that a fundamental and persistent change has occurred specifically m the secretory/biosynthetc pathway for EO. The nature of this effect is unknown but presumably involves growth factors.
When ouabam 1s present m high concentrations m the extracellular medium of certain adrenocortrcal clonal cell lines, it is accumulated in an endosomal compartment and subsequently secreted with a half-time of 40 to 50 hours The uptake and secretion of ouabam from the external phase has led some to question the orrgm of the secreted E0.31 The present results m Ag 1 obtained with primary zona glomerulosa cell cultures show that the secretion of EO and by inference the content of this steroid m the cells are affected mmrmally by prior growth m media where the external EO concentrattons vary 40-fold m the subnanomolar range. This result and previous studies m rats showing that the adrenal content of EO is independent of changes m circulating ouabam within the physrologtcal range20 suggest again that the secreted EO 1s not the result of prior sequestration from the serum This point 1s emphasized by the following calculatrons. In Fig 1, each well of cells grown in medium containing 0.3% serum was exposed over the 48 hours in culture to a total of ~6 8 fmol of EO. When washed and incubated, the cells m each of those wells secreted on average =330 fmol of EO mto the Vol29, No 1, Part 2 January 1997 secretion medium m 4 hours Therefore, the endosomal pathway involved m the sequestaatlon and secretion of extracellular ouabam is neither quantitatively nor kmettcally viable as a means to explain the secreted EO measured under our condmons.
In response to AII, the secretions of EO, aldosterone, and cortisol were consistently elevated The stimulatory effect of AI1 was blocked by SI-AI1 (Fig 5) , compattble with the hypotheses that AI1 receptors mediate steroid secretion Whereas DuP753 had no effect on AII-stimulated secretion of EO, the correspondmg secretions of aldosterone and cortisol were blocked (Fig 6) On the other hand, the sttmulatory effect of AI1 on EO secretion was completely blocked by the AT1 receptor antagonist PD at concentrations known to inhibit the bmdmg of AI1 to the AT2 receptor without affecting the AT, receptor.6,26-28 The selectivity of this antagonism was demonstrated by the lack of effect of this compound on stimulated aldosterone and corttsol secretions (Fig 7) In addition, the AT2 agonist CGP stimulated the secretion of EO but had no effect on basal or AII-stimulated aldosterone secretion. Other studies have shown that the AT2 receptor hgands PD and CGP selectively mhtbit AI1 bmdmg to AT1 receptors at concentrations that do not affect AII-stimulated secretions of aldosterone and corttso1.6.26-28 Therefore, when taken together, the present results demonstrate that AI1 shmulates secretion of EO by activating the AT2 receptor subtype. AT, and AT2 receptors have distinct signaling pathways, the latter subtype stimulatmg an orthovanadate-sensitive phosphotyrosme phosphatase.5 The role of phosphorylation m EO secretion remains to be demonstrated. However, prelmunary experiments suggest that orthovanadate blocks AII-stimulated secretion of EO from zona glomerulosaenriched primary cell cultures, a result that is consistent with the participation of phosphatase activity (J R.S. and J.M H., 1996, unpublished data)
The observation that adrenocortical cells have two classes of functional An-dependent affinities (Fig 3) also supports the notion that different receptors for AI1 are involved. Based on the pharmacological dissection presented, rt appears that the stimulated secretions of aldosterone and cortisol m response to AI1 exhibit an apparent ECso value of =0.3 nmol/L and are mediated exclusively by AT, receptors These results are consistent with the results from earlier studies 28-30 However, the present results showed that the effective dose of AI1 required (~2.3 nmol/L) for half-maximal secretion of EO was eightfold higher than that needed for aldosterone and cortrsol secretions.
Studies that evaluated the bmdmg of labeled AI1 to bovine, human, and rat adrenocorttcal membranes have suggested a single class of high-affinity sites with dissociation constants ranging broadly from 0.2 to 4.0 nmol/L.28.32-34 It seems likely that the Scatchard analyses used m some studies may not reliably discnmmate between classes of receptors whose affinities differ by less than one order of magnitude, especially where the lower affinity component represents 20% or less of the sites. Others have reported btphaslc AI1 binding to angiotensm receptors from adrenal cortex and other tissues 1-6-3s However, three lmes of evtdence suggest that the low-affinity sites identified from these binding studies may not reflect AT2 receptors First, the difference m affinity between the high-and low-affinity binding sites previously described tends to be large, typically 1 5 to 2 log units 6 Second, the dtssociation constants for the low-affinity site typically appear to he outside of the reported range for effects of AI1 (eg, rat heart Kd =50 nmolLL) Third, the low-affinity sues are not always present in cellular membranes from different tissues where AT2 receptors are now known to be present.35 Thus, the low-affinity sites for AII may represent desensitized ATI receptors or membrane-associated peptidases.6,36
The EC& for stimulated secretion of EO (~2.3 nmol/L) is =35-fold and -lo-fold higher than the level m mixed venous plasma from cattle observed under sodium-replete (-65 pmol/L) or acutely depleted (=230 pmol/L) conditions, respectively.37 The calculated concentrations of AI1 required to stimulate aldosterone and EO secretions by 10% were =42 and =250 pmol/L. Therefore, according to this analysts, the normal plasma levels of AI1 in cattle would be sufficient to stimulate aldosterone secretion by 10% to 12% and, durmg acute sodium depletion, the plasma levels of AI1 would be sufficient to provide a simalar stimulus to EO secretion Furthermore, high plasma levels of AI1 may also be an important stimulus to EO secretion m patients with rerun-secretmg tumors and m congestive heart failure 38 Renin granules have been described m the zona glomerulosa, and the results of several studies imply that the intra-adrenal concentrations of AI1 are higher than arterial blood levels by a sigmficant margm.39-41 While our results do not exclude AI1 as a tonic stimulus to EO secretion m the sodmm-replete state, they suggest that the physlologma1 role of adrenocortrcal AT2 receptors may be mcreasmgly important during prolonged adaptation to low-sodium diets, at least m free-ranging cattle Recent studies m other tissues and species seem to reinforce the notion that AT1 receptors are functionally significant under lowsodium conditions 42 In addition, AI11 stimulates aldosterone secretion and binds with greater affinity than AI1 to ATz receptors m several species, and other components of the renm-angtotensm system not explored here may be relevant to the control of EO secretion 32. 43 The bulk of human evolutton is believed to have occurred under the stress of a sodium-poor environment.4 Under such condittons, elevated clrculatmg levels of EO, like ouabam, may amplify the pressor effects of aldosterone,45 and we have suggested that this effect may have played a crmcal role m the maintenance of heightened vascular tone and normal blood pressure critical to survtva1.46 Under sodmm-replete conditions, amphfication of the effects of aldosterone by EO may be of pathologtcal significance m view of the large portion of patients with essential hypertension and Conn's syndrome m whom markedly elevated circulatmg levels of one or both steroids have been described.47
In summary, AI1 stimulates secretion of endogenous ouabam from adrenocortical cell cultures These effects appear to be mediated specifically via functional AT2 receptors and provide additional evidence that novel cellular mechanisms within the adrenal gland mediate the synthesis and secretion of polyhydroxylated steroids similar to ouabam 
